Aeovian Pharmaceuticals Inc

Aeovian Pharmaceuticals, Inc. develops biopharmaceutical solutions for rare genetic and age-related diseases. The company focuses on targeted small molecule drugs, conducts clinical trials for CNS-penetrant selective mTORC1 inhibitors, and creates proprietary inhibitor libraries. Aeovian serves patients in the US, especially those with tuberous sclerosis complex refractory epilepsy.